Ney Carter Borges/LinkedIn
Apr 26, 2026, 11:38
Ney Carter Borges: Perioperative Cardiovascular Medication Management in Noncardiac Surgery
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:
“Perioperative Cardiovascular Medication Management (Noncardiac Surgery)
Key Clinical Recommendations (AHA/ACC 2024 Guideline – JAMA 2026)
Statins
- Continue therapy perioperatively
- Initiate in high-risk patients
- Decreased mortality: 2.18% vs 3.15% (OR 0.62; 95% CI 0.58–0.67)
Aspirin
- Continue if prior PCI
- Do NOT initiate without PCI
- Increased bleeding risk: 4.6% vs 3.8% (HR 1.23; p equals 0.04)
β-blockers
- Continue if already prescribed
- Avoid initiation perioperatively
- Increased mortality: HR 1.33 (95% CI 1.03–1.74)
SGLT2 inhibitors
- Suspend before surgery
- 3 days: dapagliflozin / empagliflozin
- 4 days: ertugliflozin
- Reason: risk of euglycemic ketoacidosis
GLP-1 receptor agonists
- Consider withholding (depending on case)
- Risk: delayed gastric emptying – aspiration
- Gastric residue: 11 vs 1 (p equals 0.004).”
Other posts featuring Ney Carter Borges on Hemostasis Today.
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old
-
Sep 11, 2026, 16:44Mostafa Faisal Mohammed Saleh: From HLA Biology to Curative Therapy
-
Sep 11, 2026, 16:38Jim Kaveney: Class I, Level A – Lifestyle is Now the Official Standard in AFib Care
-
Sep 11, 2026, 16:31George Touma: Do We Really Need to Implant Metal in Every High-Bleeding-Risk Patient?